相似文献
1
S100A9-targeted tobacco mosaic virus nanoparticles exhibit high specificity toward atherosclerotic lesions in ApoE mice.
J Mater Chem B. 2019 Mar 21;7(11):1842-1846. doi: 10.1039/c8tb02276c. Epub 2019 Feb 13.
2
Dual-modal magnetic resonance and fluorescence imaging of atherosclerotic plaques in vivo using VCAM-1 targeted tobacco mosaic virus.
Nano Lett. 2014 Mar 12;14(3):1551-8. doi: 10.1021/nl404816m. Epub 2014 Feb 17.
3
S100A9-Targeted Cowpea Mosaic Virus as a Prophylactic and Therapeutic Immunotherapy against Metastatic Breast Cancer and Melanoma.
Adv Sci (Weinh). 2021 Nov;8(21):e2101796. doi: 10.1002/advs.202101796. Epub 2021 Sep 14.
4
Featured Article: Delivery of chemotherapeutic vcMMAE using tobacco mosaic virus nanoparticles.
Exp Biol Med (Maywood). 2017 Aug;242(14):1405-1411. doi: 10.1177/1535370217719222. Epub 2017 Jul 4.
5
Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.
ACS Nano. 2017 Sep 26;11(9):9249-9258. doi: 10.1021/acsnano.7b04472. Epub 2017 Sep 6.
6
Designing S100A9-Targeted Plant Virus Nanoparticles to Target Deep Vein Thrombosis.
Biomacromolecules. 2021 Jun 14;22(6):2582-2594. doi: 10.1021/acs.biomac.1c00303. Epub 2021 Jun 1.
7
In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40.
Nano Lett. 2016 Oct 12;16(10):6164-6171. doi: 10.1021/acs.nanolett.6b02386. Epub 2016 Sep 14.
8
Molecularly imprinted polymers for tobacco mosaic virus recognition.
Biomaterials. 2006 Aug;27(22):4165-8. doi: 10.1016/j.biomaterials.2006.03.018. Epub 2006 Mar 30.
9
Activatable fluorescence imaging of macrophages in atherosclerotic plaques using iron oxide nanoparticles conjugated with indocyanine green.
Atherosclerosis. 2018 Aug;275:1-10. doi: 10.1016/j.atherosclerosis.2018.05.028. Epub 2018 May 18.
10
Let There Be Light: Targeted Photodynamic Therapy Using High Aspect Ratio Plant Viral Nanoparticles.
Macromol Biosci. 2019 May;19(5):e1800407. doi: 10.1002/mabi.201800407. Epub 2019 Feb 5.
引用本文的文献
1
Metastatic Melanoma Treatment and Prophylaxis with S100A9-Targeting Cowpea Mosaic Virus Nanoparticles.
Methods Mol Biol. 2025;2902:13-36. doi: 10.1007/978-1-0716-4402-7_2.
2
Advances in the study of S100A9 in cardiovascular diseases.
Cell Prolif. 2024 Aug;57(8):e13636. doi: 10.1111/cpr.13636. Epub 2024 Mar 19.
3
Multivalent Display of ApoAI Peptides on the Surface of Tobacco Mosaic Virus Nanotubes Improves Cholesterol Efflux.
Bioconjug Chem. 2022 Oct 19;33(10):1922-1933. doi: 10.1021/acs.bioconjchem.2c00371. Epub 2022 Oct 3.
4
Bioconjugation of Active Ingredients to Plant Viral Nanoparticles Is Enhanced by Preincubation with a Pluronic F127 Polymer Scaffold.
ACS Appl Mater Interfaces. 2021 Dec 22;13(50):59618-59632. doi: 10.1021/acsami.1c13183. Epub 2021 Dec 10.
5
The fate of tobacco mosaic virus nanoparticle theranostic agents modified by the addition of a polydopamine coat.
Biomater Sci. 2021 Oct 26;9(21):7134-7150. doi: 10.1039/d1bm01113h.
6
Application of Plant Viruses in Biotechnology, Medicine, and Human Health.
Viruses. 2021 Aug 26;13(9):1697. doi: 10.3390/v13091697.
7
Recent progress in targeted delivery vectors based on biomimetic nanoparticles.
Signal Transduct Target Ther. 2021 Jun 7;6(1):225. doi: 10.1038/s41392-021-00631-2.
8
Designing S100A9-Targeted Plant Virus Nanoparticles to Target Deep Vein Thrombosis.
Biomacromolecules. 2021 Jun 14;22(6):2582-2594. doi: 10.1021/acs.biomac.1c00303. Epub 2021 Jun 1.
9
The pharmacology of plant virus nanoparticles.
Virology. 2021 Apr;556:39-61. doi: 10.1016/j.virol.2021.01.012. Epub 2021 Jan 28.
10
Recent advances in nanomaterials for therapy and diagnosis for atherosclerosis.
Adv Drug Deliv Rev. 2021 Mar;170:142-199. doi: 10.1016/j.addr.2021.01.005. Epub 2021 Jan 9.
本文引用的文献
1
Cancer Theranostic Applications of Albumin-Coated Tobacco Mosaic Virus Nanoparticles.
ACS Appl Mater Interfaces. 2018 Nov 21;10(46):39468-39477. doi: 10.1021/acsami.8b12499. Epub 2018 Nov 7.
2
Magnetic Resonance Imaging of Atherosclerotic Plaque at Clinically Relevant Field Strengths (1T) by Targeting the Integrin α4β1.
Sci Rep. 2018 Feb 27;8(1):3733. doi: 10.1038/s41598-018-21893-x.
3
Recent Advances in Managing Atherosclerosis via Nanomedicine.
Small. 2018 Jan;14(4). doi: 10.1002/smll.201702793. Epub 2017 Dec 14.
4
Dysprosium-Modified Tobacco Mosaic Virus Nanoparticles for Ultra-High-Field Magnetic Resonance and Near-Infrared Fluorescence Imaging of Prostate Cancer.
ACS Nano. 2017 Sep 26;11(9):9249-9258. doi: 10.1021/acsnano.7b04472. Epub 2017 Sep 6.
5
The immunology of atherosclerosis.
Nat Rev Nephrol. 2017 Jun;13(6):368-380. doi: 10.1038/nrneph.2017.51. Epub 2017 Apr 10.
6
Biomedical and Catalytic Opportunities of Virus-Like Particles in Nanotechnology.
Adv Virus Res. 2017;97:1-60. doi: 10.1016/bs.aivir.2016.09.002. Epub 2016 Nov 8.
7
RGD targeting of human ferritin iron oxide nanoparticles enhances in vivo MRI of vascular inflammation and angiogenesis in experimental carotid disease and abdominal aortic aneurysm.
J Magn Reson Imaging. 2017 Apr;45(4):1144-1153. doi: 10.1002/jmri.25459. Epub 2016 Sep 30.
8
In Vivo Targeting and Imaging of Atherosclerosis Using Multifunctional Virus-Like Particles of Simian Virus 40.
Nano Lett. 2016 Oct 12;16(10):6164-6171. doi: 10.1021/acs.nanolett.6b02386. Epub 2016 Sep 14.
9
Gold nanoparticles-based SPECT/CT imaging probe targeting for vulnerable atherosclerosis plaques.
Biomaterials. 2016 Nov;108:71-80. doi: 10.1016/j.biomaterials.2016.08.048. Epub 2016 Aug 31.
10
Tobacco Mosaic Virus Delivery of Phenanthriplatin for Cancer therapy.
ACS Nano. 2016 Apr 26;10(4):4119-26. doi: 10.1021/acsnano.5b07360. Epub 2016 Mar 28.
Zotero 插件